Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Promises “FastAccess” To Patient Assistance Programs

This article was originally published in The Pink Sheet Daily

Executive Summary

The Pharmaceutical Research & Manufacturers of America is creating a unified enrollment form to simplify access to industry patient assistance programs

You may also be interested in...



Former Lilly Exec Daniels Wins Indiana Governorship

The brandname industry may have an opportunity to work with Indiana to achieve its oft-stated goal of making patient assistance programs more visible and successful. Daniels supports expanded use of discount programs, including the federal 340(B) program.

Former Lilly Exec Daniels Wins Indiana Governorship

The brandname industry may have an opportunity to work with Indiana to achieve its oft-stated goal of making patient assistance programs more visible and successful. Daniels supports expanded use of discount programs, including the federal 340(B) program.

PhRMA “FastAccess” Doubles Monthly Visits To Patient Assistance Website

Approximately 100,000 visitors per month have logged onto PhRMA’s HelpingPatients.org since the “Fast Access” online patient enrollment system launch April 1. The site previously had about 50,000 visitors per month.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059305

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel